Company intelligence / Profile preview

TSI Group

Ownership: Private
Development stage: Commercial

Overview

TSI Group is a global leader in both innovative surgical access systems for neuro, spine, orthopedic, and cardiothoracic procedures as well as a major supplier of scientifically validated nutritional ingredients. Its products are widely used in clinical practice and consumer health markets worldwide. The company has demonstrated strong growth through innovation, scientific research, and strategic partnerships/acquisition by Halma.

Therapeutic areas: OtherCardiovascularRheumatologyNeurology
Modalities: DeviceSmall molecule
Industry: Surgical Medical Devices

Drug pipeline

4 assets

GlucosaGreen

Commercial

Indications: Joint health

3 more assets in the full pipeline.

Request access →

Partnerships

Not specifically listed but collaborates with leading researchers/institutions globally for R&D in both divisions.

Beyond the preview

Go deeper on TSI Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TSI Group.

Explore the full profile